Follow Us
© 2026 Arizent. All rights reserved.
Kathryn Mayer is a former editor-in-chief of Employee Benefit News.
For reprint and licensing requests for this article, click here.
While the legislation's future is still unclear, there are many important things for leaders to know.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
At parent support company Haven, CEO Britt Riley offers benefits that make employees feel taken care of.
The potential for a healthier lifestyle is extending beyond medication to lifestyle and workplace habits that create change for employees.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
